EWOC-1 Trial: Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian Cancer

NCT02001272 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Paclitaxel + Carboplatin every 3 weeks
DRUG: Carboplatin monotherapy every 3 weeks
DRUG: Weekly Paclitaxel and Carboplatin

Sponsor

Hospices Civils de Lyon